<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>HGM Advisory — HealthTech &amp; AI Insights</title>
    <link>https://www.hgm-advisory.com/insights</link>
    <description>HealthTech &amp; AI analysis — trends, funding rounds, regulatory developments, and strategic insights for healthcare leaders.</description>
    <language>en</language>
    <lastBuildDate>Sun, 05 Apr 2026 00:53:35 GMT</lastBuildDate>
    <atom:link href="https://www.hgm-advisory.com/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title><![CDATA[Mayo Clinic Platform Accelerate: 76 AI startups and the data-for-equity model reshaping clinical AI]]></title>
      <link>https://www.hgm-advisory.com/insights/mayo-clinic-platform-accelerate</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/mayo-clinic-platform-accelerate</guid>
      <pubDate>Fri, 03 Apr 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Mayo Clinic announced 18 AI HealthTech startups for cohort 7 of its Platform Accelerate program, bringing the total to 76 AI startups since 2022. The data-for-equity model, where Mayo provides patient data, clinical validation, and FDA guidance in exchange for equity, is becoming a blueprint for how academic medical centers can systematically accelerate clinical AI.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[German public payors are losing billions: the funding gap could reach €40B by 2030]]></title>
      <link>https://www.hgm-advisory.com/insights/german-payor-funding-gap</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/german-payor-funding-gap</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Public payors in Germany are losing billions every year. If nothing changes, the funding gap could reach €40B by 2030, roughly 10% of projected €400B+ GKV spending. Short-term fixes from the Health Finance Commission won't be enough: the system needs a structural reset.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AI in hospitals: outsourced, hybrid, or homegrown? 3 operating models to scale AI]]></title>
      <link>https://www.hgm-advisory.com/insights/ai-hospitals-operating-models</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/ai-hospitals-operating-models</guid>
      <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[AI in hospitals: outsourced, hybrid, or homegrown? 3 operating models to scale AI]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Tech x Outpatient Care: Heidi, Doctolib and Eterno are redefining the ambulatory tech stack]]></title>
      <link>https://www.hgm-advisory.com/insights/tech-outpatient-care</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/tech-outpatient-care</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Tech x Outpatient Care: Heidi, Doctolib and Eterno are redefining the ambulatory tech stack]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[HealthTech failures: lessons that today's AI healthcare companies should study]]></title>
      <link>https://www.hgm-advisory.com/insights/healthtech-failures</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/healthtech-failures</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[HealthTech failures: lessons that today's AI healthcare companies should study]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Health x Claude & ChatGPT: Claude positions itself as infrastructure, ChatGPT focuses on consumers]]></title>
      <link>https://www.hgm-advisory.com/insights/health-claude-chatgpt</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/health-claude-chatgpt</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Health x Claude & ChatGPT: Claude positions itself as infrastructure, ChatGPT focuses on consumers]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Hospital IT: European hospitals at a crossroads]]></title>
      <link>https://www.hgm-advisory.com/insights/hospital-it-european</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/hospital-it-european</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Hospital IT: European hospitals at a crossroads]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[HealthTech & AI in 2025: clinical AI breaks through, agentic AI falls short]]></title>
      <link>https://www.hgm-advisory.com/insights/healthtech-ai-2025-review</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/healthtech-ai-2025-review</guid>
      <pubDate>Tue, 20 Jan 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Clinical AI (with OpenEvidence) made a breakthrough, while agentic AI has not delivered on its promises yet. A review of the events that shaped HealthTech & AI in 2025 across clinical AI, hospital IT, agentic AI, consumer health, and MedTech acquisitions.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AMBOSS Lisa 1.0 tops the NOHARM AI-CDS benchmark study]]></title>
      <link>https://www.hgm-advisory.com/insights/amboss-lisa-noharm-study</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/amboss-lisa-noharm-study</guid>
      <pubDate>Sat, 10 Jan 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[Lisa 1.0 by German company AMBOSS achieved the highest score in the NOHARM study, outperforming Google, Glass Health, OpenAI, Alibaba, and human physicians. The study tests how safely AI systems make medical decisions across 100+ clinical cases.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[258 AI algorithms approved by the FDA in 2025 — a record year]]></title>
      <link>https://www.hgm-advisory.com/insights/fda-ai-algorithms-2025</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/fda-ai-algorithms-2025</guid>
      <pubDate>Mon, 05 Jan 2026 00:00:00 GMT</pubDate>
      <description><![CDATA[In 2025, 258 AI algorithms were approved by the FDA, the highest number so far. 1,387 AI-enabled medical devices have been approved total, mostly in radiology (79%), followed by cardiovascular (10%) and neurology (5%). Top 20 companies led by GE HealthCare, Siemens, and Shanghai United Imaging.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Radiology AI: a blueprint for all clinical AI categories]]></title>
      <link>https://www.hgm-advisory.com/insights/radiology-ai-blueprint</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/radiology-ai-blueprint</guid>
      <pubDate>Mon, 15 Dec 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[As the most advanced clinical AI category, Radiology AI should serve as a blueprint for understanding potential winners and losers across all clinical AI. Four scenarios emerge: MedTech incumbent wins, aggregator wins, full-stack platform wins, or specialized carve-out wins.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AI-CDS: OpenEvidence becomes the go-to AI tool for doctors]]></title>
      <link>https://www.hgm-advisory.com/insights/ai-clinical-decision-support-openevidence</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/ai-clinical-decision-support-openevidence</guid>
      <pubDate>Mon, 01 Dec 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[OpenEvidence shows no sign of slowing down, becoming the go-to AI tool for doctors in the US. Competitors like UpToDate, Amboss, Synapse, and others are reacting as AI-clinical decision support reshapes medical practice.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[D2C Pharma: price pressure accelerates direct-to-consumer models]]></title>
      <link>https://www.hgm-advisory.com/insights/d2c-pharma-models</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/d2c-pharma-models</guid>
      <pubDate>Sat, 15 Nov 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Price pressure in the US is accelerating D2C models in pharma, particularly in the cardiometabolic space. Five examples — PfizerForAll, Lilly Direct, NovoCare, AmgenNow, and AstraZeneca Direct — show how these models are likely to expand beyond the US, especially for GLP-1.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[HealthTech maturity index: which categories are leading?]]></title>
      <link>https://www.hgm-advisory.com/insights/healthtech-maturity-index</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/healthtech-maturity-index</guid>
      <pubDate>Wed, 15 Oct 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Patient solutions, CareOps and medical diagnostics are the most mature HealthTech categories. A maturity index mapping 13 categories from early-stage venture to maturing businesses, with 3 leading scale-ups in each.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Healthcare Tech Stack: AI redefines hospitals & outpatient care]]></title>
      <link>https://www.hgm-advisory.com/insights/healthcare-tech-stack</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/healthcare-tech-stack</guid>
      <pubDate>Mon, 15 Sep 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Incumbents and newcomers are fighting hard as AI redefines the tech stack. Epic, Oracle Cerner, Doximity, OpenEvidence, OpenAI, and Tempus are all making major moves in the battle for the healthcare tech stack.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AI agents are scaling in outpatient care]]></title>
      <link>https://www.hgm-advisory.com/insights/ai-agents-outpatient-care</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/ai-agents-outpatient-care</guid>
      <pubDate>Fri, 15 Aug 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Hippocratic AI, Commure, Nabla, Tandem — AI agents are now scaling. Outpatient care needs a tech upgrade. Vertical AI agents (scribes, decision support, billing) now solve problems better than legacy EHR systems.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[OpenEvidence raises $210M at $3.5B valuation]]></title>
      <link>https://www.hgm-advisory.com/insights/openevidence-funding-series-b</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/openevidence-funding-series-b</guid>
      <pubDate>Tue, 15 Jul 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[OpenEvidence, the fastest-growing physician app, is now in 10K+ U.S. hospitals with 8.5M monthly consultations. DeepConsult AI agents synthesize real-time clinical evidence at the point of care.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AI scribes: Nabla, Tandem Health, and Abridge headline a market at an inflection point]]></title>
      <link>https://www.hgm-advisory.com/insights/ai-scribes-market-2025</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/ai-scribes-market-2025</guid>
      <pubDate>Thu, 03 Jul 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[In June 2025, AI scribes made headlines: Nabla raised $70M Series C, Tandem Health secured $50M, and Abridge reached a $5B valuation. But low barriers to entry, rising regulation, and incumbent counter-moves make this a market where strategy matters more than technology.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[CB Insights Pharma AI Readiness Index]]></title>
      <link>https://www.hgm-advisory.com/insights/pharma-ai-readiness-index</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/pharma-ai-readiness-index</guid>
      <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Lilly jumped to #1, Merck to #2, Roche fell to 5th, while J&J, Novartis, and GSK dropped out of the Top 10. AI in pharma R&D shows huge potential but limited delivery so far.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[The new operating system of healthcare: what Commure's $200M raise means for hospitals]]></title>
      <link>https://www.hgm-advisory.com/insights/healthcare-operating-system-commure</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/healthcare-operating-system-commure</guid>
      <pubDate>Thu, 26 Jun 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Commure raised $200M to build the 'new operating system of healthcare.' Drawing parallels to fintech's unbundling-rebundling cycle, this analysis explores how Commure, Innovaccer, and emerging European players are assembling the next-generation hospital platform.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[As we enter the post-EHR era, it's worth understanding who won the first battle: Epic]]></title>
      <link>https://www.hgm-advisory.com/insights/epic-ehr-dominance</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/epic-ehr-dominance</guid>
      <pubDate>Tue, 13 May 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Epic dominates the EHR market with a unified codebase and unmatched reliability. But as we enter the post-EHR era, with AI, unbundling, and new care models reshaping healthcare IT, the question is whether Epic's dominance will hold or fracture.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Mayo Clinic Platform Accelerate selects 15 AI startups: clinical AI, Japan's rise, and the hospital innovation blueprint]]></title>
      <link>https://www.hgm-advisory.com/insights/mayo-clinic-cohort-5-ai-startups</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/mayo-clinic-cohort-5-ai-startups</guid>
      <pubDate>Thu, 01 May 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Mayo Clinic Platform Accelerate selected 15 AI HealthTech startups for its latest cohort, bringing the total to 45+ since 2022. 7 of 15 focus on preventative or predictive health, and 4 are from Japan, signaling the emergence of Japan's AI HealthTech ecosystem on the global stage.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[European HealthTech ecosystems: France leads funding, but capital alone does not build champions]]></title>
      <link>https://www.hgm-advisory.com/insights/european-healthtech-ecosystems</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/european-healthtech-ecosystems</guid>
      <pubDate>Tue, 11 Mar 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[A comparative analysis of HealthTech ecosystems across France, Germany, Spain, and Italy. France leads funding (Doctolib ~$870M, Alan ~$800M), but ecosystem maturity depends equally on networks, policies, and industry trust. The EHDS will accelerate cross-border expansion.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Healthcare AI agents: Dragon Copilot, Oracle, Salesforce, and the weekly avalanche of new launches]]></title>
      <link>https://www.hgm-advisory.com/insights/healthcare-ai-agents-market-disruption</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/healthcare-ai-agents-market-disruption</guid>
      <pubDate>Thu, 06 Mar 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[New AI agents in healthcare are being announced every week: Microsoft Dragon Copilot, Oracle Health Clinical AI Agent across 30+ specialties, Salesforce, Talkdesk, Deepgram. First results emerge: 60% burnout reduction, 30% less documentation time. But most European health systems are not ready.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AI agents in hospitals: only the top 5% can implement them today]]></title>
      <link>https://www.hgm-advisory.com/insights/ai-agents-adoption-gap-hospitals</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/ai-agents-adoption-gap-hospitals</guid>
      <pubDate>Thu, 20 Feb 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Innovaccer (backed by Kaiser Permanente) is launching 7 AI agents. Mayo Clinic is investing in UIPath and VoccaCare AI. But for 95%+ of hospitals, AI agents are at least five years away. The gap between leading and regional hospitals is widening, and it will force smaller hospitals to shut down.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[AI alone outperforms physician-assisted AI in radiology: what it means for the field]]></title>
      <link>https://www.hgm-advisory.com/insights/ai-outperforms-physician-assisted-ai-radiology</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/ai-outperforms-physician-assisted-ai-radiology</guid>
      <pubDate>Tue, 04 Feb 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Recent studies suggest AI alone outperforms physician-assisted AI in diagnostics, from chest X-rays to mammography. Eric Topol calls it 'highly counterintuitive.' If confirmed, this reshapes radiology AI investment, physician training, and hospital operating models.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Neko Health raises $260M at $1.8B: the rise of D2C clinical healthcare]]></title>
      <link>https://www.hgm-advisory.com/insights/neko-health-d2c-clinical</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/neko-health-d2c-clinical</guid>
      <pubDate>Wed, 29 Jan 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Neko Health (co-founded by Spotify's Daniel Ek) raised $260M at $1.8B valuation. Andreessen Horowitz believes 'the biggest company in the world will be a consumer HealthTech company.' But D2C clinical is still a massive false positive generator, and for many categories, the science is too early.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Big Tech meets Big VC meets Big Pharma: the new power plays reshaping HealthTech]]></title>
      <link>https://www.hgm-advisory.com/insights/big-tech-vc-partnerships-dedalus</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/big-tech-vc-partnerships-dedalus</guid>
      <pubDate>Thu, 23 Jan 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[General Catalyst partners with AWS. Andreessen Horowitz launches a TechBio fund with Eli Lilly. Kaiser Permanente builds a post-EHR data layer with Innovaccer. And legacy EHR provider Dedalus is up for sale. The power dynamics in healthcare technology are shifting fast.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Hippocratic AI launches an AI agent app store for healthcare at $1.6B valuation]]></title>
      <link>https://www.hgm-advisory.com/insights/hippocratic-ai-agent-app-store</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/hippocratic-ai-agent-app-store</guid>
      <pubDate>Wed, 15 Jan 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Hippocratic AI (backed by General Catalyst, $141M Series B, $1.6B valuation) announced an AI agent app store where physicians can create their own agents in under 30 minutes and earn revenue share. Could AI agent ecosystems leapfrog existing hospital solutions entirely?]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
    <item>
      <title><![CDATA[Lessons from 2024: AI agents, AI scribes, and CompuGroup going private]]></title>
      <link>https://www.hgm-advisory.com/insights/lessons-2024-healthtech</link>
      <guid isPermaLink="true">https://www.hgm-advisory.com/insights/lessons-2024-healthtech</guid>
      <pubDate>Thu, 09 Jan 2025 00:00:00 GMT</pubDate>
      <description><![CDATA[Three key events from 2024 that will shape healthcare's future: Hippocratic AI and Nvidia proving AI agents are 16-43% better than nurses at specific tasks (at $9/hour vs $39/hour); AI scribes entering medical practices as 'the most transformative thing in 15 years'; and CompuGroup going private to rebuild its legacy EHR.]]></description>
      <author>thomas.hagemeijer@hgm-advisory.com (Thomas Hagemeijer)</author>
    </item>
  </channel>
</rss>